ESR1 and breast carcinoma: Other investigations of ARHGDIA in the context of cancer have indicated a role in estrogen receptor signalling (and estrogen responsiveness) in breast cancer[35,36] and association with poor prognosis in colorectal cancer[37] consistent with our previous, similar findings in MPM[20-22,37].